Targeting	O
Src	B-protein
homology	I-protein
2	I-protein
domain-containing	I-protein
tyrosine	I-protein
phosphatase	I-protein
(	O
SHP-1	B-protein
)	O
into	O
lipid	O
rafts	O
inhibits	O
CD3	B-protein
-induced	O
T	B-cell_type
cell	I-cell_type
activation	O
.	O

To	O
study	O
the	O
mechanism	O
by	O
which	O
protein	B-protein
tyrosine	I-protein
phosphatases	I-protein
(	O
PTPs	B-protein
)	O
regulate	O
CD3	B-protein
-induced	O
tyrosine	O
phosphorylation	O
,	O
we	O
investigated	O
the	O
distribution	O
of	O
PTPs	B-protein
in	O
subdomains	O
of	O
plasma	O
membrane	O
.	O

We	O
report	O
here	O
that	O
the	O
bulk	O
PTP	B-protein
activity	O
associated	O
with	O
T	B-cell_type
cell	I-cell_type
membrane	O
is	O
present	O
outside	O
the	O
lipid	O
rafts	O
,	O
as	O
determined	O
by	O
sucrose	O
density	O
gradient	O
sedimentation	O
.	O

In	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
approximately	O
5	O
--	O
10	O
%	O
of	O
Src	B-protein
homology	I-protein
2	I-protein
domain-containing	I-protein
tyrosine	I-protein
phosphatase	I-protein
(	O
SHP-1	B-protein
)	O
is	O
constitutively	O
associated	O
with	O
plasma	O
membrane	O
,	O
and	O
nearly	O
50	O
%	O
of	O
SHP-2	B-protein
is	O
translocated	O
to	O
plasma	O
membrane	O
after	O
vanadate	O
treatment	O
.	O

Similar	O
to	O
transmembrane	B-protein
PTP	I-protein
,	O
CD45	B-protein
,	O
the	O
membrane-associated	O
populations	O
of	O
SHP-1	B-protein
and	O
SHP-2	B-protein
are	O
essentially	O
excluded	O
from	O
lipid	O
rafts	O
,	O
where	O
other	O
signaling	B-protein
molecules	I-protein
such	O
as	O
Lck	B-protein
,	I-protein
linker	I-protein
for	I-protein
activation	I-protein
of	I-protein
T	I-protein
cells	I-protein
,	O
and	O
CD3	B-protein
zeta	I-protein
are	O
enriched	O
.	O

We	O
further	O
demonstrated	O
that	O
CD3	B-protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
these	O
substrates	O
is	O
largely	O
restricted	O
to	O
lipid	O
rafts	O
,	O
unless	O
PTPs	B-protein
are	O
inhibited	O
.	O

It	O
suggests	O
that	O
a	O
restricted	O
partition	O
of	O
PTPs	B-protein
among	O
membrane	O
subdomains	O
may	O
regulate	O
protein	O
tyrosine	O
phosphorylation	O
in	O
T	B-cell_type
cell	I-cell_type
membrane	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
targeted	O
SHP-1	B-protein
into	O
lipid	O
rafts	O
by	O
using	O
the	O
N-terminal	B-protein
region	I-protein
of	I-protein
Lck	I-protein
(	O
residues	B-protein
1	I-protein
--	I-protein
14	I-protein
)	O
.	O

The	O
results	O
indicate	O
that	O
the	O
expression	O
of	O
Lck/SHP-1	B-protein
chimera	I-protein
inside	O
lipid	O
rafts	O
profoundly	O
inhibits	O
CD3	B-protein
-induced	O
tyrosine	O
phosphorylation	O
of	O
CD3	B-protein
zeta/epsilon	I-protein
,	O
IL-2	O
generation	O
,	O
and	O
nuclear	O
mobilization	O
of	O
NF-AT	B-protein
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
the	O
exclusion	O
of	O
PTPs	B-protein
from	O
lipid	O
rafts	O
may	O
be	O
a	O
mechanism	O
that	O
potentiates	O
TCR	B-protein
/	O
CD3	B-protein
activation	O

``	NULL
Th	NULL
VIVO	NULL
v	NULL
RE	NULL
SEAR	NULL
GCH	NULL
£	NULL
Discover	NULL
More	NULL
Me	NULL
BULK	NULL
ANTIBODIES	NULL
sam-	NULL
s	NULL
Afst	NULL
me	NULL
Journal	NULL
of	NULL
Targeting	NULL
Src	NULL
Homology	NULL
2	NULL
Domain-Containing	NULL
Tyrosine	NULL
Phosphatase	NULL
ImmunOIOgy	NULL
(	NULL
SHP	NULL
-1	NULL
)	NULL
into	NULL
Lipid	NULL
Rafts	NULL
Inhibits	NULL
CD3-Induced	NULL
T	NULL
Cell	NULL
Activation	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Michael	NULL
Wei-Chih	NULL
Su	NULL
,	NULL
Chao-Lan	NULL
Yu	NULL
,	NULL
Steven	NULL
J.	NULL
Burakoff	NULL
and	NULL
Yong-Jiu	NULL
Jin	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
166:3975-3982	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.166.6.3975	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/6/3975	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
42	NULL
articles	NULL
,	NULL
23	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/166/6/3975	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Targeting	NULL
Src	NULL
Homology	NULL
2	NULL
Domain-Containing	NULL
Tyrosine	NULL
Phosphatase	NULL
(	NULL
SHP	NULL
into	NULL
Lipid	NULL
Rafts	NULL
Inhibits	NULL
CD3-Induced	NULL
T	NULL
Cell	NULL
Activation	NULL
Michael	NULL
Wei-Chih	NULL
Su	NULL
,	NULL
Chao-Lan	NULL
Yu	NULL
,	NULL
Steven	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
Yong-Jiu	NULL
Jin	NULL
``	NULL
To	NULL
study	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
(	NULL
PTPs	NULL
)	NULL
regulate	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
distribution	NULL
of	NULL
PTPs	NULL
in	NULL
subdomains	NULL
of	NULL
plasma	NULL
membrane	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
bulk	NULL
PTP	NULL
activity	NULL
associated	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
is	NULL
present	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
sucrose	NULL
density	NULL
gradient	NULL
sedimentation	NULL
.	NULL

In	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
~5-10	NULL
%	NULL
of	NULL
Sre	NULL
homology	NULL
2	NULL
domain-containing	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
SHP	NULL
is	NULL
constitutively	NULL
associated	NULL
with	NULL
plasma	NULL
membrane	NULL
,	NULL
and	NULL
nearly	NULL
50	NULL
%	NULL
of	NULL
SHP-2	NULL
is	NULL
translocated	NULL
to	NULL
plasma	NULL
membrane	NULL
after	NULL
vanadate	NULL
treatment	NULL
.	NULL

Similar	NULL
to	NULL
transmembrane	NULL
PTP	NULL
,	NULL
CD45	NULL
,	NULL
the	NULL
membrane-associated	NULL
populations	NULL
of	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
are	NULL
essentially	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
,	NULL
where	NULL
other	NULL
signaling	NULL
molecules	NULL
such	NULL
as	NULL
Lek	NULL
,	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
CD3	NULL
are	NULL
enriched	NULL
.	NULL

We	NULL
further	NULL
demonstrated	NULL
that	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
substrates	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
lipid	NULL
rafts	NULL
,	NULL
unless	NULL
PTPs	NULL
are	NULL
inhibited	NULL
.	NULL

It	NULL
suggests	NULL
that	NULL
a	NULL
restricted	NULL
partition	NULL
of	NULL
PTPs	NULL
among	NULL
membrane	NULL
subdomains	NULL
may	NULL
regulate	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
targeted	NULL
SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
by	NULL
using	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
Lek	NULL
(	NULL
residues	NULL
1-14	NULL
)	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
Lek/SHP-1	NULL
chimera	NULL
inside	NULL
lipid	NULL
rafts	NULL
profoundly	NULL
inhibits	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3	NULL
{	NULL
e	NULL
,	NULL
IL-2	NULL
generation	NULL
,	NULL
and	NULL
nuclear	NULL
mobilization	NULL
of	NULL
NF-AT	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
exclusion	NULL
of	NULL
PTPs	NULL
from	NULL
lipid	NULL
rafts	NULL
may	NULL
be	NULL
a	NULL
mechanism	NULL
that	NULL
potentiates	NULL
TCR/CD3	NULL
activation	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
166	NULL
:	NULL
3975-3982.	NULL
phosphorylation	NULL
of	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activa-	NULL
tion	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tails	NULL
of	NULL
CD3	NULL
subunits	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activation	NULL
motifs	NULL
by	NULL
Src	NULL
family	NULL
kinases	NULL
leads	NULL
to	NULL
the	NULL
recruitment	NULL
and	NULL
phosphorylation	NULL
of	NULL
ZAP70/Syk	NULL
family	NULL
protein	NULL
kinases	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
results	NULL
in	NULL
the	NULL
subsequent	NULL
phosphorylation	NULL
and	NULL
complex	NULL
formation	NULL
of	NULL
signaling	NULL
molecules	NULL
,	NULL
including	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
LAT	NULL
)	NULL
,	NULL
``	NULL
Grb2	NULL
,	NULL
Vav	NULL
,	NULL
SH2	NULL
domain-containing	NULL
Leukocyte	NULL
Protein	NULL
of	NULL
76	NULL
kDa	NULL
(	NULL
SLP-76	NULL
)	NULL
,	NULL
and	NULL
murine	NULL
Sons	NULL
of	NULL
Sevenless	NULL
(	NULL
mSOS	NULL
)	NULL
(	NULL
3-7	NULL
)	NULL
.	NULL

This	NULL
links	NULL
TCR	NULL
stimulation	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
downstream	NULL
path-ways	NULL
,	NULL
such	NULL
as	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
,	NULL
and	NULL
phospholipase	NULL
C-y1	NULL
,	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
compartmentalization	NULL
of	NULL
membrane	NULL
structure	NULL
imposed	NULL
by	NULL
lipid	NULL
rafts	NULL
is	NULL
essential	NULL
for	NULL
TCR-medi-ated	NULL
signaling	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Lipid	NULL
rafts	NULL
have	NULL
been	NULL
described	NULL
as	NULL
a	NULL
mobile	NULL
and	NULL
dynamic	NULL
membrane	NULL
structure	NULL
with	NULL
a	NULL
diameter	NULL
of	NULL
70-300	NULL
nm	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
that	NULL
used	NULL
confocal	NULL
microscopy	NULL
have	NULL
shown	NULL
that	NULL
stimulation	NULL
by	NULL
TCR	NULL
,	NULL
CD2	NULL
,	NULL
or	NULL
CD3/CD28	NULL
induces	NULL
reorganization	NULL
and	NULL
clustering	NULL
of	NULL
lipid	NULL
raft	NULL
microdomains	NULL
at	NULL
the	NULL
site	NULL
of	NULL
en-gagement	NULL
,	NULL
which	NULL
lead	NULL
to	NULL
enhanced	NULL
TCR	NULL
signaling	NULL
and	NULL
a	NULL
higher	NULL
and	NULL
S	NULL
timulation	NULL
of	NULL
the	NULL
TCR/CD3	NULL
complex	NULL
induces	NULL
tyrosine	NULL
Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Received	NULL
for	NULL
publication	NULL
September	NULL
19	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
January	NULL
5	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
request	NULL
to	NULL
Dr.	NULL
Yong-fiu	NULL
Jin	NULL
,	NULL
Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Room	NULL
M654	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
yong-jtu_jin	NULL
@	NULL
dfci.harvard.edu	NULL
2	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LAT	NULL
,	NULL
linker	NULL
for	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
;	NULL
PTP	NULL
,	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
anti-pTyr	NULL
:	NULL
anti-phosphotyrosine	NULL
Ab	NULL
;	NULL
NP-40	NULL
Nonidet	NULL
P-40	NULL
;	NULL
pNpp	NULL
,	NULL
p-nitrophenyl	NULL
phosphate	NULL
;	NULL
SHP	NULL
,	NULL
Src	NULL
homology	NULL
protein	NULL
2	NULL
domain-containing	NULL
tyrosine	NULL
phosphatase	NULL
;	NULL
SIRP	NULL
or	NULL
SHPS-1	NULL
,	NULL
signal-regulatory	NULL
proteins	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
more	NULL
stable	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

Discrete	NULL
lipid	NULL
rafts	NULL
are	NULL
enriched	NULL
in	NULL
molecules	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
,	NULL
such	NULL
as	NULL
Sre	NULL
family	NULL
kinases	NULL
,	NULL
Ras	NULL
,	NULL
and	NULL
G	NULL
proteins	NULL
,	NULL
as	NULL
well	NULL
as	NULL
sphingolipid	NULL
,	NULL
cholesterol	NULL
,	NULL
and	NULL
a	NULL
subset	NULL
of	NULL
GPI-linked	NULL
proteins	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

Studies	NULL
in	NULL
T	NULL
cells	NULL
revealed	NULL
that	NULL
CD34	NULL
,	NULL
coreceptor	NULL
CD4	NULL
and	NULL
CD8	NULL
,	NULL
Src	NULL
family	NULL
kinase	NULL
Lok	NULL
and	NULL
Fyn	NULL
,	NULL
and	NULL
transmembrane	NULL
adaptor	NULL
LAT	NULL
are	NULL
also	NULL
concentrated	NULL
in	NULL
lipid	NULL
rafts	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD45	NULL
,	NULL
a	NULL
receptor-type	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
PTP	NULL
)	NULL
,	NULL
is	NULL
so	NULL
far	NULL
the	NULL
only	NULL
phosphatase	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
coordinated	NULL
action	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
and	NULL
PTPs	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
the	NULL
segregation	NULL
of	NULL
PTKs	NULL
and	NULL
PTPs	NULL
on	NULL
T	NULL
cell	NULL
membrane	NULL
is	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
CD45	NULL
,	NULL
PTPs	NULL
Sre	NULL
homology	NULL
2	NULL
domain-containing	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
SHP-1	NULL
)	NULL
and	NULL
SHP-2	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

SHP-1	NULL
is	NULL
expressed	NULL
primarily	NULL
in	NULL
hemopoietic	NULL
cells	NULL
and	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
negative	NULL
regulation	NULL
of	NULL
signaling	NULL
and	NULL
development	NULL
.	NULL

Accordingly	NULL
,	NULL
thymocytes	NULL
derived	NULL
from	NULL
motheaten	NULL
(	NULL
me	NULL
)	NULL
mice	NULL
,	NULL
which	NULL
lack	NULL
the	NULL
expression	NULL
of	NULL
functional	NULL
SHP-1	NULL
,	NULL
hyperproliferate	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
stimulation	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
SHP-2	NULL
is	NULL
known	NULL
for	NULL
its	NULL
requirement	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
Ras/mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
in	NULL
nonhemopoietic	NULL
cells	NULL
and	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
SHP-2	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
TCR	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
CTLA-4	NULL
and	NULL
possibly	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
dephosphorylation	NULL
of	NULL
CD3	NULL
subunits	NULL
(	NULL
31-33	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
precise	NULL
functions	NULL
of	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
as	NULL
regulators	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
when	NULL
isolated	NULL
T	NULL
cell	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
PTP	NULL
inhibitors	NULL
H	NULL
,	NULL
O	NULL
;	NULL
or	NULL
vanadate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
,	NULL
the	NULL
molecules	NULL
enriched	NULL
in	NULL
lipid	NULL
rafts	NULL
,	NULL
such	NULL
as	NULL
CD3	NULL
and	NULL
protein	NULL
kinases	NULL
Lck	NULL
,	NULL
Fyn	NULL
,	NULL
Syk	NULL
,	NULL
and	NULL
ZAP70	NULL
,	NULL
were	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
PTP	NULL
activity	NULL
is	NULL
found	NULL
predominantly	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
and	NULL
identify	NULL
SHP-1	NULL
and	NULL
0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3976	NULL
PTPs	NULL
RESTRICT	NULL
CD3-INDUCED	NULL
TYR	NULL
PHOSPHORYLATION	NULL
TO	NULL
LIPID	NULL
RAFTS	NULL
SHP-2	NULL
as	NULL
two	NULL
important	NULL
membrane-associated	NULL
PTPs	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
restricted	NULL
distribution	NULL
of	NULL
PTPs	NULL
in	NULL
membrane	NULL
microdomains	NULL
was	NULL
further	NULL
demonstrated	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
CD3-induced	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
IL-2	NULL
generation	NULL
,	NULL
and	NULL
NE-AT	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
SHP-1	NULL
targeted	NULL
to	NULL
lipid	NULL
rafts	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
restricted	NULL
distribution	NULL
of	NULL
PTPs	NULL
in	NULL
membrane	NULL
microdomains	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
TCR/CD3	NULL
signaling	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
and	NULL
Abs	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
J77	NULL
,	NULL
a	NULL
variant	NULL
of	NULL
clone	NULL
E6-1	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
humidified	NULL
atmosphere	NULL
.	NULL

JCD45	NULL
~	NULL
(	NULL
145.01	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
ATCC	NULL
.	NULL

Anti-phosphotyrosine	NULL
Ab	NULL
(	NULL
anti-pTyr	NULL
;	NULL
RC20	NULL
)	NULL
and	NULL
anti-SHP-1	NULL
mAbs	NULL
were	NULL
purchased	NULL
from	NULL
BD	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

and	NULL
anti-CD45	NULL
mAbs	NULL
as	NULL
well	NULL
as	NULL
anti-SHP-2	NULL
polyclonal	NULL
Ab	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-LAT	NULL
and	NULL
anti-Lck	NULL
polyclonal	NULL
Abs	NULL
were	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Anti-CD3	NULL
Ab	NULL
(	NULL
OKT3	NULL
)	NULL
and	NULL
anti-Myc	NULL
Ab	NULL
were	NULL
prepared	NULL
from	NULL
a	NULL
hy-bridoma	NULL
obtained	NULL
from	NULL
ATCC	NULL
.	NULL

T	NULL
cell	NULL
stimulation	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
immunoblotting	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
.	NULL

For	NULL
CD3	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
OKT3	NULL
(	NULL
2	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
5	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
cross-linked	NULL
by	NULL
rabbit	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
an	NULL
additional	NULL
5	NULL
min	NULL
,	NULL
then	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
min	NULL
.	NULL

For	NULL
H	NULL
,	NULL
O	NULL
,	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
mM	NULL
H	NULL
;	NULL
0	NULL
;	NULL
at	NULL
37°C	NULL
for	NULL
3	NULL
min	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
PBS	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.5	NULL
%	NULL
sodium	NULL
deoxy-cholate	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
2	NULL
pg/ml	NULL
antipain	NULL
)	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
NP-40	NULL
lysate	NULL
was	NULL
centrifuged	NULL
at	NULL
12,000	NULL
X	NULL
g	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
conducted	NULL
at	NULL
4°C	NULL
overnight	NULL
or	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
4	NULL
h	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100/TBS	NULL
and	NULL
once	NULL
with	NULL
TBS	NULL
.	NULL

Proteins	NULL
were	NULL
eluted	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
boiling	NULL
for	NULL
5	NULL
min	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
Laemmli	NULL
reducing	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Proteins	NULL
from	NULL
~10	NULL
'	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
fluoride	NULL
membrane	NULL
.	NULL

Membrane	NULL
were	NULL
blocked	NULL
with	NULL
3	NULL
%	NULL
BSA	NULL
in	NULL
TBST	NULL
and	NULL
incubated	NULL
with	NULL
Abs	NULL
in	NULL
TBST	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
four	NULL
15-min	NULL
washes	NULL
with	NULL
TBST	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
HRP-conjugated	NULL
Ab	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
5	NULL
min	NULL
with	NULL
TBST	NULL
,	NULL
and	NULL
developed	NULL
using	NULL
the	NULL
ECL	NULL
system	NULL
(	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Subcellular	NULL
fractionation	NULL
After	NULL
washing	NULL
in	NULL
PBS	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
hypotonic	NULL
buffer	NULL
(	NULL
42	NULL
mM	NULL
KCI	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
passed	NULL
through	NULL
a	NULL
30-gauge	NULL
needle	NULL
10	NULL
times	NULL
,	NULL
follwed	NULL
by	NULL
centrifugation	NULL
at	NULL
250	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
to	NULL
remove	NULL
the	NULL
nuclei	NULL
and	NULL
intact	NULL
cells	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
centrifuged	NULL
at	NULL
150,000	NULL
X	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
to	NULL
separate	NULL
the	NULL
cytoplasm	NULL
from	NULL
the	NULL
membrane	NULL
fraction	NULL
.	NULL

For	NULL
sucrose	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
the	NULL
membrane	NULL
fraction	NULL
was	NULL
lysed	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
a	NULL
panel	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
adjusted	NULL
to	NULL
1.33	NULL
M	NULL
sucrose	NULL
by	NULL
adding	NULL
1	NULL
ml	NULL
of	NULL
85	NULL
%	NULL
sucrose	NULL
in	NULL
TNE	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

In	NULL
a	NULL
SW41	NULL
centrifuge	NULL
tube	NULL
,	NULL
the	NULL
lysate	NULL
was	NULL
overlaid	NULL
with	NULL
7	NULL
ml	NULL
of	NULL
30	NULL
%	NULL
and	NULL
3.5	NULL
ml	NULL
of	NULL
5	NULL
%	NULL
sucrose	NULL
in	NULL
TNE	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
centrifuged	NULL
for	NULL
16-17	NULL
h	NULL
at	NULL
38,000	NULL
rpm	NULL
.	NULL

After	NULL
equilibrium	NULL
centrifugation	NULL
,	NULL
the	NULL
gradients	NULL
were	NULL
fractionated	NULL
from	NULL
the	NULL
top	NULL
by	NULL
1.5	NULL
ml	NULL
volume	NULL
.	NULL

Phosphatase	NULL
activity	NULL
assays	NULL
For	NULL
assays	NULL
that	NULL
used	NULL
p-nitrophenyl	NULL
phosphate	NULL
(	NULL
pNpp	NULL
)	NULL
as	NULL
the	NULL
substrate	NULL
,	NULL
50	NULL
pul	NULL
of	NULL
membrane	NULL
suspension	NULL
(	NULL
ODgy	NULL
,	NULL
=	NULL
6.0	NULL
)	NULL
was	NULL
mixed	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
2	NULL
%	NULL
assay	NULL
buffer	NULL
containing	NULL
100	NULL
mM	NULL
pNpp	NULL
,	NULL
100	NULL
mM	NULL
2-	NULL
(	NULL
N-morpholino	NULL
)	NULL
ethanesulfonic	NULL
acid	NULL
at	NULL
pH	NULL
5.5	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
EDTA	NULL
and	NULL
incubated	NULL
at	NULL
25°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
cuvettes	NULL
containing	NULL
0.9	NULL
ml	NULL
of	NULL
1	NULL
%	NULL
NaOH	NULL
for	NULL
OD	NULL
reading	NULL
at	NULL
450	NULL
nm	NULL
.	NULL

For	NULL
assays	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
as	NULL
the	NULL
substrate	NULL
,	NULL
the	NULL
membrane	NULL
fraction	NULL
was	NULL
first	NULL
incubated	NULL
with	NULL
1	NULL
mM	NULL
vanadate	NULL
at	NULL
4°C	NULL
for	NULL
10	NULL
min	NULL
to	NULL
inhibit	NULL
PTP	NULL
activity	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
13,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
1.5	NULL
ml	NULL
of	NULL
cold	NULL
hypotonic	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
adjusted	NULL
to	NULL
concentration	NULL
of	NULL
6.0	NULL
OD	NULL
reading	NULL
at	NULL
600	NULL
nm	NULL
wavelength	NULL
.	NULL

Fifty	NULL
microliters	NULL
of	NULL
vanadate-treated	NULL
membrane	NULL
suspension	NULL
was	NULL
used	NULL
as	NULL
substrate	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
reaction	NULL
mixture	NULL
,	NULL
which	NULL
was	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

One	NULL
millimolar	NULL
ATP	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
mixture	NULL
for	NULL
3	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
precipitated	NULL
by	NULL
centrifugation	NULL
at	NULL
13,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
and	NULL
then	NULL
solublized	NULL
in	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
membrane	NULL
proteins	NULL
was	NULL
determined	NULL
by	NULL
anti-pTyr	NULL
(	NULL
4G10	NULL
)	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
anti-pTyr	NULL
(	NULL
RC20	NULL
)	NULL
immunoblotting	NULL
.	NULL

For	NULL
assays	NULL
with	NULL
purified	NULL
phosphatases	NULL
,	NULL
the	NULL
Escherichia	NULL
coli-overexpressed	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
glutathione-Sepharose	NULL
affinity	NULL
column	NULL
,	NULL
and	NULL
the	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
pNpp	NULL
assay	NULL
with	NULL
the	NULL
enzyme	NULL
unit	NULL
of	NULL
T	NULL
cell	NULL
PTP	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
as	NULL
standard	NULL
.	NULL

Construction	NULL
,	NULL
transfection	NULL
,	NULL
and	NULL
stable	NULL
expression	NULL
of	NULL
Lck/SHP-1	NULL
plasmid	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
To	NULL
construct	NULL
Lek/SHP-1	NULL
fusion	NULL
plasmid	NULL
,	NULL
PCR	NULL
was	NULL
performed	NULL
with	NULL
human	NULL
SHP-1	NULL
template	NULL
with	NULL
PCR	NULL
primers	NULL
5'-ATGGGCTGTGGCTGCAGCTCA	NULL
CACCCGGAAGATGACTGGATGGAGACCCTGCTCAAGGGCCGAGG	NULL
TGTC	NULL
(	NULL
underlined	NULL
42	NULL
nucleotides	NULL
are	NULL
from	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
Lek	NULL
)	NULL
and	NULL
5-CTTCCTCTTGAGGGAACCCTTGCTCTTC	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
subcloned	NULL
into	NULL
mammalian	NULL
expression	NULL
vector	NULL
pEF	NULL
,	NULL
/Myc-His	NULL
(	NULL
Invitrogen	NULL
,	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
,	NULL
Lek/SHP-1	NULL
was	NULL
digested	NULL
by	NULL
Bgill	NULL
and	NULL
Eagl	NULL
!	NULL

and	NULL
religated	NULL
by	NULL
blunt-end	NULL
ligation	NULL
,	NULL
which	NULL
removed	NULL
a	NULL
DNA	NULL
fragment	NULL
of	NULL
144	NULL
bp	NULL
.	NULL

Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
cDNA	NULL
encodes	NULL
a	NULL
mutant	NULL
SHP-1	NULL
protein	NULL
with	NULL
a	NULL
48-aa	NULL
truncation	NULL
from	NULL
residues	NULL
409-457	NULL
.	NULL

The	NULL
sequence	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
107/500	NULL
pl	NULL
)	NULL
by	NULL
electroporation	NULL
with	NULL
the	NULL
settings	NULL
of	NULL
800	NULL
uF	NULL
,	NULL
low	NULL
ohm	NULL
,	NULL
and	NULL
250	NULL
V.	NULL
The	NULL
clones	NULL
with	NULL
stable	NULL
expression	NULL
of	NULL
Lek/SHP-1	NULL
or	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
selected	NULL
in	NULL
medium	NULL
containing	NULL
neomycin	NULL
(	NULL
G418	NULL
)	NULL
at	NULL
2.5	NULL
mg/ml	NULL
.	NULL

Luciferase	NULL
assays	NULL
Luciferase	NULL
assay	NULL
was	NULL
conducted	NULL
with	NULL
dual-luciferase	NULL
reporter	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WD	NULL
)	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
)	NULL
with	NULL
stable	NULL
expression	NULL
of	NULL
Leck/SHP-1	NULL
or	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pNF-AT-Luciferase	NULL
together	NULL
with	NULL
1	NULL
pug	NULL
of	NULL
pRenilla-luciferase	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
25	NULL
ml	NULL
of	NULL
medium	NULL
for	NULL
16-20	NULL
h.	NULL
Cells	NULL
were	NULL
aliquoted	NULL
into	NULL
a	NULL
24-well	NULL
plate	NULL
to	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
per	NULL
well	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
culture	NULL
medium	NULL
for	NULL
subsequent	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
,	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
CD3	NULL
plus	NULL
PMA	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
plus	NULL
1	NULL
uM	NULL
ionomycin	NULL
.	NULL

After	NULL
6-8	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
PBS	NULL
.	NULL

Harvested	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
and	NULL
dual-luciferase	NULL
activity	NULL
was	NULL
quantitated	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruction	NULL
with	NULL
a	NULL
monolight	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
Ann	NULL
Arbor	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
triplicate	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
.	NULL

ELISA	NULL
of	NULL
IL-2	NULL
in	NULL
supernatants	NULL
Anti-CD3	NULL
mAb	NULL
(	NULL
OKT3	NULL
,	NULL
100	NULL
pul	NULL
of	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

was	NULL
immobilized	NULL
on	NULL
an	NULL
enzyme	NULL
immunoassay	NULL
RIA	NULL
96-well	NULL
Costar	NULL
microtiter	NULL
plate	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
sterile	NULL
PBS	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Wells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
10°	NULL
Jurkat	NULL
T	NULL
cells	NULL
to	NULL
wells	NULL
containing	NULL
PMA	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
measured	NULL
for	NULL
IL-2	NULL
by	NULL
standard	NULL
ELISA	NULL
techniques	NULL
with	NULL
paired	NULL
capture	NULL
and	NULL
detection	NULL
anti-IL-2	NULL
Abs	NULL
(	NULL
OptEIA	NULL
;	NULL
BD	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Results	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
phosphatases	NULL
are	NULL
predominantly	NULL
localized	NULL
in	NULL
Triton	NULL
X-100	NULL
soluble	NULL
,	NULL
nonlipid	NULL
raft	NULL
membrane	NULL
fractions	NULL
To	NULL
date	NULL
,	NULL
the	NULL
distribution	NULL
of	NULL
phosphatases	NULL
in	NULL
the	NULL
cytoplasmic	NULL
membrane	NULL
of	NULL
T	NULL
lymphocytes	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
characterized	NULL
.	NULL

Given	NULL
our	NULL
knowledge	NULL
of	NULL
the	NULL
importance	NULL
of	NULL
lipid	NULL
rafts	NULL
in	NULL
the	NULL
propagation	NULL
of	NULL
signal	NULL
transduction	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
identify	NULL
the	NULL
location	NULL
of	NULL
phosphatases	NULL
in	NULL
relation	NULL
to	NULL
lipid	NULL
microdomains	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
segregated	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
into	NULL
nine	NULL
fractions	NULL
with	NULL
sucrose	NULL
gradient	NULL
sedimentation	NULL
,	NULL
of	NULL
which	NULL
fractions	NULL
3	NULL
and	NULL
4	NULL
are	NULL
enriched	NULL
in	NULL
lipid	NULL
rafts	NULL
(	NULL
insoluble	NULL
in	NULL
Triton	NULL
X-100	NULL
)	NULL
and	NULL
fractions	NULL
8	NULL
and	NULL
9	NULL
are	NULL
derived	NULL
from	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
(	NULL
soluble	NULL
in	NULL
Triton	NULL
X-100	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
first	NULL
identified	NULL
the	NULL
position	NULL
of	NULL
phosphatases	NULL
by	NULL
measuring	NULL
PTP	NULL
activities	NULL
in	NULL
each	NULL
gradient	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
middle	NULL
and	NULL
right	NULL
)	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
PTP	NULL
activity	NULL
is	NULL
essentially	NULL
located	NULL
in	NULL
fractions	NULL
8	NULL
and	NULL
9	NULL
,	NULL
or	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
.	NULL

A	NULL
likely	NULL
candidate	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
3977	NULL
CD45+	NULL
CD45-1.4	NULL
1.4	NULL
1.4	NULL
1.2	NULL
1.2	NULL
Z	NULL
1.2	NULL
g	NULL
12	NULL
g	NULL
1	NULL
f	NULL
g	NULL
1.2	NULL
c	NULL
c	NULL
A|	NULL
S	NULL
@	NULL
|	NULL
@	NULL
|	NULL
A|	NULL
a	NULL
|	NULL
<	NULL
4	NULL
<	NULL
7	NULL
T	NULL
@	NULL
y	NULL
A|	NULL
2	NULL
os	NULL
0	NULL
U8	NULL
3	NULL
98	NULL
Z	NULL
A|	NULL
|	NULL
(	NULL
0.8	NULL
§	NULL
o	NULL
3	NULL
]	NULL
|	NULL
g.	NULL
g	NULL
.0	NULL
g	NULL
0.6	NULL
z	NULL
2	NULL
g	NULL
6	NULL
A	NULL
A	NULL
.	NULL

<	NULL
A	NULL
A	NULL
0	NULL
,	NULL
$	NULL
04	NULL
3	NULL
94	NULL
a	NULL
2	NULL
3	NULL
°	NULL
7	NULL
0.2	NULL
0.2	NULL
A	NULL
A|	NULL
-	NULL
``	NULL
7	NULL
A	NULL
P	NULL
f	NULL
0	NULL
0	NULL
t	NULL
A_	NULL
P	NULL
0	NULL
10	NULL
.	NULL

A	NULL
bo	NULL
2	NULL
3	NULL
40	NULL
$	NULL
060	NULL
7	NULL
%	NULL
O9	NULL
Io	NULL
20	NULL
3	NULL
4	NULL
§	NULL
0	NULL
60	NULL
70s	NULL
9	NULL
Fraction	NULL
Number	NULL
Fraction	NULL
Number	NULL
FIGURE	NULL
1	NULL
.	NULL

-	NULL
Distribution	NULL
of	NULL
PTP	NULL
activity	NULL
in	NULL
membrane	NULL
fractions	NULL
of	NULL
sucrose	NULL
density	NULL
gradient	NULL
.	NULL

T	NULL
cell	NULL
membranes	NULL
were	NULL
prepared	NULL
from	NULL
CD45	NULL
*	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
CD45	NULL
(	NULL
J45.01	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
PTP	NULL
activity	NULL
present	NULL
in	NULL
either	NULL
the	NULL
total	NULL
membrane	NULL
fraction	NULL
(	NULL
Zef	NULL
?	NULL
)	NULL

or	NULL
individual	NULL
sucrose	NULL
density	NULL
gradient	NULL
fraction	NULL
(	NULL
middle	NULL
and	NULL
right	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
using	NULL
pNpp	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

The	NULL
PTP	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
release	NULL
of	NULL
nitrophenyl	NULL
phosphate	NULL
,	NULL
which	NULL
was	NULL
measured	NULL
at	NULL
450	NULL
nm	NULL
.	NULL

membrane-associated	NULL
phosphatase	NULL
would	NULL
be	NULL
CD45	NULL
,	NULL
a	NULL
transmembrane	NULL
PTP	NULL
known	NULL
to	NULL
be	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
total	NULL
PTP	NULL
activity	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
to	NULL
its	NULL
mutant	NULL
cell	NULL
line	NULL
(	NULL
J45.01	NULL
)	NULL
lacking	NULL
the	NULL
expression	NULL
of	NULL
CD45	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
membrane	NULL
of	NULL
J45.01	NULL
T	NULL
cells	NULL
still	NULL
contained	NULL
~40	NULL
%	NULL
of	NULL
the	NULL
PTPs	NULL
activity	NULL
as	NULL
compared	NULL
with	NULL
its	NULL
parental	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Zeff	NULL
)	NULL
.	NULL

The	NULL
phosphatases	NULL
that	NULL
remain	NULL
in	NULL
145.01	NULL
T	NULL
cells	NULL
shared	NULL
a	NULL
similar	NULL
distribution	NULL
of	NULL
PTP	NULL
activity	NULL
as	NULL
the	NULL
parental	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
right	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
CD45	NULL
and	NULL
other	NULL
membrane-resident	NULL
phosphatases	NULL
are	NULL
basically	NULL
excluded	NULL
from	NULL
lipid	NULL
microdomains	NULL
.	NULL

SHP-1	NULL
is	NULL
a	NULL
phosphatase	NULL
described	NULL
to	NULL
associate	NULL
with	NULL
a	NULL
number	NULL
of	NULL
substrates	NULL
,	NULL
of	NULL
which	NULL
some	NULL
are	NULL
associated	NULL
with	NULL
plasma	NULL
membrane	NULL
,	NULL
such	NULL
as	NULL
ZAP70	NULL
,	NULL
CD3e	NULL
,	NULL
CD5	NULL
,	NULL
leukocyte-associated	NULL
Ig-like	NULL
recep-tor-1	NULL
,	NULL
and	NULL
signal-regulatory	NULL
proteins	NULL
(	NULL
SIRP	NULL
or	NULL
SHPS-1	NULL
;	NULL
Refs	NULL
.	NULL

26	NULL
,	NULL
35-39	NULL
)	NULL
.	NULL

In	NULL
additional	NULL
to	NULL
CTLA-4	NULL
,	NULL
SHP-2	NULL
also	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
membrane	NULL
anchor	NULL
proteins	NULL
such	NULL
as	NULL
SIRP	NULL
or	NULL
SHPS-1	NULL
and	NULL
Protein	NULL
Zero	NULL
Related	NULL
(	NULL
PZR	NULL
)	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Given	NULL
their	NULL
importance	NULL
in	NULL
regulating	NULL
TCR	NULL
signaling	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
examine	NULL
whether	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
cytoplasmic	NULL
membrane	NULL
.	NULL

To	NULL
address	NULL
this	NULL
issue	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
fractionated	NULL
into	NULL
cytosolic	NULL
or	NULL
membrane	NULL
fractions	NULL
with	NULL
or	NULL
without	NULL
vanadate	NULL
,	NULL
an	NULL
in-hibitor	NULL
of	NULL
PTPs	NULL
known	NULL
to	NULL
induce	NULL
potent	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
top	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
~5-10	NULL
%	NULL
of	NULL
SHP-1	NULL
was	NULL
associated	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
,	NULL
and	NULL
this	NULL
level	NULL
increased	NULL
after	NULL
vanadate	NULL
treatment	NULL
.	NULL

SHP-2	NULL
did	NULL
not	NULL
associate	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
in	NULL
basal	NULL
state	NULL
.	NULL

However	NULL
,	NULL
after	NULL
vanadate	NULL
treatment	NULL
,	NULL
nearly	NULL
half	NULL
of	NULL
SHP-2	NULL
was	NULL
recruited	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

This	NULL
population	NULL
of	NULL
SHP-2	NULL
appeared	NULL
to	NULL
migrate	NULL
at	NULL
a	NULL
higher	NULL
position	NULL
on	NULL
SDS-PAGE	NULL
,	NULL
which	NULL
is	NULL
probably	NULL
because	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
distribution	NULL
of	NULL
PTP	NULL
activity	NULL
in	NULL
lipid	NULL
microdomains	NULL
,	NULL
Fig	NULL
.	NULL

2B	NULL
shows	NULL
that	NULL
,	NULL
after	NULL
vanadate	NULL
treatment	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
were	NULL
present	NULL
in	NULL
Triton	NULL
X-100	NULL
soluble	NULL
fractions	NULL
8	NULL
and	NULL
9	NULL
or	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
SHP-2	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
fraction	NULL
3	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
PTPs	NULL
also	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
other	NULL
signaling	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
CD3F	NULL
,	NULL
Lek	NULL
,	NULL
and	NULL
LAT	NULL
,	NULL
which	NULL
are	NULL
enriched	NULL
in	NULL
lipid	NULL
rafts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
we	NULL
found	NULL
that	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
CD45	NULL
PTPs	NULL
were	NULL
highly	NULL
concentrated	NULL
in	NULL
fractions	NULL
8	NULL
and	NULL
9	NULL
or	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
,	NULL
whereas	NULL
CD34	NULL
,	NULL
Lok	NULL
and	NULL
LAT	NULL
were	NULL
enriched	NULL
in	NULL
Triton	NULL
X-100-insoluble	NULL
fractions	NULL
3	NULL
and	NULL
4	NULL
.	NULL

Stimulation	NULL
by	NULL
anti-CD3	NULL
Ab	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
distribution	NULL
of	NULL
SHP-1	NULL
.	NULL

Likewise	NULL
,	NULL
SHP-2	NULL
was	NULL
not	NULL
found	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
until	NULL
the	NULL
cells	NULL
were	NULL
A	NULL
Cc	NULL
moc	NULL
m	NULL
B	NULL
Sucrose	NULL
Gradient	NULL
Fraction	NULL
Va	NULL
~	NULL
-	NULL
%	NULL
%	NULL
3	NULL
40	NULL
506	NULL
7	NULL
8	NULL
g	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
67	NULL
8	NULL
9	NULL
SHP-2	NULL
ts	NULL
we	NULL
tp	NULL
SHP-2	NULL
ae	NULL
CA	NULL
)	NULL
c	NULL
CD3	NULL
-	NULL
CD3	NULL
+	NULL
Fraction	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
oo	NULL
|	NULL
mint	NULL
)	NULL
|	NULL
Hp	NULL
]	NULL
she	NULL
|	NULL
«	NULL
@	NULL
a	NULL
|	NULL
«	NULL
as	NULL
)	NULL
nra	NULL
|	NULL
|	NULL
|	NULL
«	NULL
«	NULL
~	NULL
_-	NULL
-i	NULL
_	NULL
a	NULL
-	NULL
|	NULL
|	NULL
4	NULL
L-	NULL
46	NULL
|	NULL
_	NULL
FIGURE	NULL
2	NULL
.	NULL

Distribution	NULL
of	NULL
membrane-associated	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
in	NULL
microdomains	NULL
.	NULL

A	NULL
,	NULL
Localization	NULL
of	NULL
SHP-land	NULL
SHP-2	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
treated	NULL
(	NULL
+	NULL
)	NULL
with	NULL
1	NULL
mM	NULL
vanadate	NULL
were	NULL
fractionated	NULL
into	NULL
cytosolic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
membrane	NULL
(	NULL
M	NULL
)	NULL
fractions	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-SHP-1	NULL
Ab	NULL
or	NULL
anti-SHP-2	NULL
Ab	NULL
(	NULL
bottom	NULL
)	NULL
,	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-SHP-1	NULL
Ab	NULL
(	NULL
fop	NULL
)	NULL
and	NULL
anti-SHP-2	NULL
Ab	NULL
(	NULL
bottom	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
Detection	NULL
of	NULL
membrane-associated	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
in	NULL
microdomains	NULL
.	NULL

Vanadate-treated	NULL
Jurkat	NULL
T	NULL
cell	NULL
membrane	NULL
was	NULL
segregated	NULL
into	NULL
nine	NULL
fractions	NULL
by	NULL
sucrose	NULL
density	NULL
gradient	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
boiled	NULL
in	NULL
20	NULL
ul	NULL
of	NULL
2X	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
resolved	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-SHP-1	NULL
(	NULL
top	NULL
)	NULL
or	NULL
anti-SHP-2	NULL
(	NULL
bottom	NULL
)	NULL
Ab	NULL
.	NULL

C	NULL
,	NULL
Comparison	NULL
of	NULL
microdomain	NULL
distribution	NULL
of	NULL
PTPs	NULL
with	NULL
other	NULL
T	NULL
cell	NULL
signaling	NULL
molecules	NULL
.	NULL

T	NULL
cell	NULL
membranes	NULL
were	NULL
isolated	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
unstimulated	NULL
(	NULL
CD3~	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
CD3	NULL
*	NULL
)	NULL
with	NULL
OKT3	NULL
and	NULL
segregated	NULL
by	NULL
sucrose	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
each	NULL
gradient	NULL
fraction	NULL
was	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
as	NULL
described	NULL
above	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-CD45	NULL
,	NULL
anti-SHP-1	NULL
,	NULL
anti-SHP-2	NULL
,	NULL
anti-CD34	NULL
,	NULL
anti-Lck	NULL
,	NULL
and	NULL
anti-LAT	NULL
Abs	NULL
.	NULL

LAT|	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3978	NULL
PTPs	NULL
RESTRICT	NULL
CD3-INDUCED	NULL
TYR	NULL
PHOSPHORYLATION	NULL
TO	NULL
LIPID	NULL
RAFTS	NULL
A	NULL
cos	NULL
-	NULL
CD3	NULL
+	NULL
Fraction	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
CD3	NULL
CD34	NULL
<	NULL
»	NULL
B	NULL
pVa+	NULL
pVa-Fraction	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
12	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9°	NULL
L	NULL
ll.-—.1I	NULL
'	NULL
FIGURE	NULL
3	NULL
.	NULL

Restriction	NULL
of	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
membrane	NULL
microdomains	NULL
.	NULL

A	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
CD3~	NULL
)	NULL
or	NULL
stimulated	NULL
by	NULL
CD3	NULL
cross-linking	NULL
(	NULL
CD3*	NULL
)	NULL
.	NULL

Isolated	NULL
membranes	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
sucrose	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
gradient	NULL
fraction	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
%	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
at	NULL
4°C	NULL
for	NULL
4	NULL
h.	NULL
Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
by	NULL
anti-pTyr	NULL
mAb	NULL
(	NULL
4G10	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
HRP-conjugated	NULL
anti-pTyr	NULL
Ab	NULL
(	NULL
RC20	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Membranes	NULL
isolated	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
unstimulated	NULL
(	NULL
pVa~	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
0.1	NULL
mM	NULL
pervanadate	NULL
(	NULL
pVa*	NULL
)	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
A.	NULL
CD3	NULL
:	NULL
CD3	NULL
;	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
Ab	NULL
.	NULL

Although	NULL
the	NULL
distribution	NULL
of	NULL
Lek	NULL
and	NULL
LAT	NULL
appeared	NULL
unchanged	NULL
after	NULL
stimulation	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
CD3Z	NULL
in	NULL
lipid	NULL
rafts	NULL
(	NULL
fractions	NULL
3	NULL
and	NULL
4	NULL
)	NULL
appeared	NULL
to	NULL
have	NULL
increased	NULL
slightly	NULL
.	NULL

All	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
as	NULL
well	NULL
as	NULL
CD45	NULL
phosphatases	NULL
are	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
,	NULL
and	NULL
their	NULL
distribution	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
location	NULL
of	NULL
bulk	NULL
PTP	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3	NULL
and	NULL
CD3€	NULL
was	NULL
detected	NULL
predominantly	NULL
in	NULL
Triton	NULL
X-100-insoluble	NULL
lipid	NULL
raft	NULL
membrane	NULL
fractions	NULL
To	NULL
investigate	NULL
whether	NULL
the	NULL
restricted	NULL
distribution	NULL
of	NULL
PTPs	NULL
in	NULL
membrane	NULL
subdomains	NULL
could	NULL
affect	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
pTyr	NULL
)	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
membrane	NULL
subdomains	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3Z	NULL
and	NULL
CD3€e	NULL
was	NULL
observed	NULL
mainly	NULL
in	NULL
control	NULL
__	NULL
SHP-1	NULL
(	NULL
unit	NULL
)	NULL
_	NULL
SHP-2	NULL
(	NULL
unit	NULL
)	NULL
TP	NULL
0	NULL
0	NULL
0.21	NULL
3	NULL
5	NULL
10	NULL
20	NULL
1	NULL
3	NULL
5	NULL
10	NULL
a	NULL
_+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
8a7-	NULL
u	NULL
:	NULL
3	NULL
tow	NULL
&	NULL
64-7	NULL
‘	NULL
1	NULL
'	NULL
t4	NULL
14	NULL
52_	NULL
#	NULL
..	NULL
b	NULL
4	NULL
I	NULL
o	NULL
as	NULL
39-	NULL
.Q.n..	NULL
tue	NULL
26-©	NULL
-	NULL
=a	NULL
15	NULL
“	NULL
.	NULL
'	NULL

--	NULL
«	NULL
#	NULL
#	NULL
a	NULL
B	NULL
Control	NULL
_SHP-1	NULL
SHP-2	NULL
CD45	NULL
Min	NULL
_0	NULL
1	NULL
3	NULL
5101	NULL
3	NULL
510	NULL
1	NULL
3	NULL
510	NULL
1	NULL
3	NULL
510	NULL
T	NULL
87-	NULL
i	NULL
;	NULL
H6	NULL
i	NULL
64	NULL
-	NULL
&	NULL
.n	NULL
#	NULL
4	NULL
52	NULL
-	NULL
e	NULL
a	NULL
«	NULL
~	NULL
Ba	NULL
@	NULL
«	NULL
©	NULL
39	NULL
-	NULL
CO	NULL
...	NULL
-Ge	NULL
@	NULL
c	NULL
*lessseses	NULL
>	NULL
>	NULL
15	NULL
--	NULL
®	NULL
0	NULL
...	NULL
»	NULL
@	NULL
u	NULL
.	NULL

FIGURE	NULL
4	NULL
.	NULL

|	NULL
Inhibition	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
isolated	NULL
T	NULL
cell	NULL
membranes	NULL
by	NULL
purified	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
.	NULL

A	NULL
,	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
quantitatively	NULL
inhibited	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cell	NULL
membranes	NULL
.	NULL

GST-fusion	NULL
proteins	NULL
of	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
containing	NULL
PTP	NULL
activity	NULL
ranging	NULL
from	NULL
0.2	NULL
to	NULL
20	NULL
U	NULL
were	NULL
incubated	NULL
with	NULL
vanadate	NULL
(	NULL
Va	NULL
)	NULL
-pretreated	NULL
T	NULL
cell	NULL
membrane	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

After	NULL
incubation	NULL
with	NULL
ATP	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
membrane	NULL
proteins	NULL
was	NULL
determined	NULL
by	NULL
anti-pTyr	NULL
(	NULL
4G10	NULL
)	NULL
immunoprecipitation	NULL
and	NULL
anti-pTyr	NULL
(	NULL
RC20	NULL
)	NULL
immunoblotting	NULL
.	NULL

Lanes	NULL
7	NULL
and	NULL
2	NULL
are	NULL
membrane	NULL
controls	NULL
with	NULL
or	NULL
without	NULL
vanadate	NULL
treatment	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
,	NULL
Time	NULL
course	NULL
of	NULL
tyrosine	NULL
dephosphorylation	NULL
of	NULL
membrane	NULL
proteins	NULL
with	NULL
purified	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
CD45	NULL
.	NULL

Vanadate-pretreated	NULL
T	NULL
cell	NULL
membranes	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
ATP	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Tyrosine-phosphorylated	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
either	NULL
buffer	NULL
control	NULL
or	NULL
3	NULL
U	NULL
of	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
or	NULL
CD45	NULL
for	NULL
1-10	NULL
min	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
membrane	NULL
proteins	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
A.	NULL
Molecular	NULL
mass	NULL
standards	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
lef	NULL
?	NULL

in	NULL
kDa	NULL
.	NULL

fractions	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
,	NULL
which	NULL
corresponded	NULL
to	NULL
materials	NULL
derived	NULL
from	NULL
lipid	NULL
rafts	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3Z	NULL
and	NULL
CD3e	NULL
in	NULL
fractions	NULL
8	NULL
or	NULL
9	NULL
,	NULL
where	NULL
they	NULL
colocalize	NULL
with	NULL
phosphatases	NULL
,	NULL
was	NULL
only	NULL
minimal	NULL
.	NULL

However	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
vanadate	NULL
exhibited	NULL
a	NULL
remarkably	NULL
different	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Proteins	NULL
,	NULL
including	NULL
CD3Z	NULL
and	NULL
CD3¢e	NULL
,	NULL
were	NULL
phosphorylated	NULL
in	NULL
virtually	NULL
all	NULL
the	NULL
membrane	NULL
fractions	NULL
,	NULL
including	NULL
those	NULL
where	NULL
phosphatases	NULL
were	NULL
located	NULL
(	NULL
fraction	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

A	NULL
relative	NULL
high	NULL
level	NULL
of	NULL
basal	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

But	NULL
basal	NULL
phosphorylation	NULL
of	NULL
CD3	NULL
and	NULL
CD3¢e	NULL
was	NULL
consistently	NULL
detected	NULL
only	NULL
in	NULL
lipid	NULL
raft	NULL
fractions	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

34	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
may	NULL
be	NULL
restricted	NULL
to	NULL
lipid	NULL
rafts	NULL
by	NULL
phosphatases	NULL
like	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
CD45	NULL
.	NULL

Phosphorylation	NULL
of	NULL
substrates	NULL
outside	NULL
the	NULL
lipid	NULL
rafts	NULL
may	NULL
be	NULL
suppressed	NULL
by	NULL
the	NULL
dominance	NULL
of	NULL
phosphatases	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A.	NULL
Schematic	NULL
map	NULL
of	NULL
chimeric	NULL
Lck/SHP-1	NULL
1	NULL
245	NULL
sos_s95	NULL
causup	NULL
__	NULL
|	NULL
su2	NULL
|	NULL
sh2	NULL
PTP	NULL
aul	NULL
)	NULL
ras	NULL
Myc-ta	NULL
Lek	NULL
AA	NULL
1-14	NULL
yore	NULL
1	NULL
sos	NULL
Le/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
[	NULL
su2	NULL
|	NULL
su2	NULL
|	NULL
___	NULL
PtP	NULL
___|	NULL
lCuilI	NULL
409	NULL
457	NULL
deletion	NULL
B	NULL
WT	NULL
_	NULL
Lo/SHP-1	NULL
(	NULL
aP	NULL
)	NULL
Let/SHP-1	NULL
WT	NULL
_	NULL
Lo/SHP-1	NULL
(	NULL
aP	NULL
)	NULL
Le/SHP-1	NULL
C	NULL
M	NULL
_C	NULL
M	NULL
°C	NULL
M	NULL
C	NULL
MC	NULL
MC	NULL
M	NULL
ee	NULL
«	NULL
»	NULL
<	NULL
C	NULL
-s	NULL
«	NULL
--	NULL
Gib	NULL
»	NULL
-e	NULL
gued	NULL
|	NULL
gurl	NULL
)	NULL
ame	NULL
ec	NULL
Blot	NULL
:	NULL
Anti-SHP-1	NULL
Anti-Myc	NULL
C	NULL
Lck/SHP-1	NULL
Fraction	NULL
1	NULL
-	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
170	NULL
8	NULL
9	NULL
Lek/SHP-1	NULL
|	NULL
--	NULL
am	NULL
d-|	NULL
cma	NULL
;	NULL
|	NULL
Mil	NULL
-|	NULL
Lck|	NULL
__	NULL
«	NULL
--	NULL
f	NULL
»	NULL
LAT	NULL
<	NULL
em	NULL
>	NULL
i	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
Io	NULL
O2	NULL
O3	NULL
40050	NULL
6007	NULL
80	NULL
9	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
C	NULL
be	NULL
l	NULL
Lok	NULL
|	NULL
-S-	NULL
-	NULL
~|	NULL
LAT	NULL
|_	NULL
dW	NULL
»	NULL
Ci	NULL
|	NULL
FIGURE	NULL
5	NULL
.	NULL

Targeting	NULL
SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
by	NULL
the	NULL
construction	NULL
of	NULL
chimeric	NULL
Lck/SHP-1	NULL
.	NULL

A	NULL
,	NULL
Schematic	NULL
map	NULL
of	NULL
chimeric	NULL
Lek/SHP-1	NULL
and	NULL
Lck/	NULL
SHP-1	NULL
(	NULL
AP	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Expression	NULL
and	NULL
subcellular	NULL
localization	NULL
of	NULL
Lek/SHP-1	NULL
and	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
Lck/SHP-1	NULL
or	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
fractionated	NULL
into	NULL
cytosolic	NULL
(	NULL
C	NULL
)	NULL
and	NULL
membrane	NULL
(	NULL
M	NULL
)	NULL
fractions	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-SHP-1	NULL
Ab	NULL
,	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-SHP-1	NULL
(	NULL
Zef	NULL
?	NULL

f	NULL
)	NULL
or	NULL
anti-Myc	NULL
(	NULL
right	NULL
)	NULL
Ab	NULL
.	NULL

C	NULL
,	NULL
Microdomain	NULL
distribution	NULL
of	NULL
membrane-associated	NULL
Lck/	NULL
SHP-1	NULL
,	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
CD34	NULL
,	NULL
Lok	NULL
,	NULL
and	NULL
LAT	NULL
.	NULL

Membranes	NULL
were	NULL
isolated	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
Lck/SHP-1	NULL
(	NULL
¢op	NULL
)	NULL
or	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
(	NULL
bottom	NULL
)	NULL
and	NULL
segregated	NULL
by	NULL
sucrose	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Proteins	NULL
in	NULL
each	NULL
fraction	NULL
were	NULL
solubilized	NULL
in	NULL
NP-40	NULL
lysis	NULL
buffer	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-SHP-1	NULL
Ab	NULL
followed	NULL
by	NULL
immunoblotting	NULL
analysis	NULL
with	NULL
anti-Myc	NULL
Ab	NULL
;	NULL
or	NULL
40	NULL
pil	NULL
of	NULL
each	NULL
fraction	NULL
was	NULL
immunoblotted	NULL
with	NULL
anti-CD3¢	NULL
,	NULL
anti-Lck	NULL
,	NULL
and	NULL
anti-LAT	NULL
.	NULL

SHP-1	NULL
and	NULL
SHP-2	NULL
inhibits	NULL
membrane	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
To	NULL
investigate	NULL
whether	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
relative	NULL
efficiencies	NULL
of	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
CD45	NULL
phosphatases	NULL
in	NULL
inhibiting	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

As	NULL
shown	NULL
3979	NULL
C	NULL
0	NULL
&	NULL
2	NULL
``	NULL
€	NULL
f	NULL
&	NULL
y	NULL
£	NULL
CD32	NULL
cost	NULL
10	NULL
,	NULL
FIGURE	NULL
6	NULL
.	NULL

Inhibition	NULL
of	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
Lck/SHP-1	NULL
.	NULL

Wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
or	NULL
Lek/SHP-1	NULL
either	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
OKT3	NULL
.	NULL

Isolated	NULL
membranes	NULL
were	NULL
segregated	NULL
into	NULL
nine	NULL
fractions	NULL
by	NULL
sucrose	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Fraction	NULL
3	NULL
of	NULL
each	NULL
gradient	NULL
was	NULL
analyzed	NULL
for	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3.	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
both	NULL
purified	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
could	NULL
quantitatively	NULL
block	NULL
the	NULL
overall	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
purified	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
€D45	NULL
on	NULL
substrate	NULL
dephosphorylation	NULL
were	NULL
further	NULL
compared	NULL
in	NULL
a	NULL
time	NULL
course	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
both	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
dephosphorylated	NULL
proteins	NULL
within	NULL
5	NULL
min	NULL
of	NULL
incubation	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
CD45	NULL
was	NULL
less	NULL
effective	NULL
at	NULL
the	NULL
same	NULL
catalytic	NULL
units	NULL
,	NULL
as	NULL
the	NULL
dephosphorylation	NULL
of	NULL
proteins	NULL
was	NULL
less	NULL
apparent	NULL
even	NULL
after	NULL
10	NULL
min	NULL
.	NULL

N-terminal	NULL
region	NULL
of	NULL
Lok	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
localization	NULL
of	NULL
SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
If	NULL
perpetual	NULL
exclusion	NULL
of	NULL
PTPs	NULL
from	NULL
lipid	NULL
microdomains	NULL
is	NULL
necessary	NULL
to	NULL
protect	NULL
phosphorylated	NULL
molecules	NULL
from	NULL
phosphatases	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
PTPs	NULL
in	NULL
lipid	NULL
rafts	NULL
may	NULL
diminish	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
targeted	NULL
SHP-1	NULL
phosphatase	NULL
into	NULL
lipid	NULL
microdomains	NULL
by	NULL
using	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
Lek	NULL
,	NULL
which	NULL
contains	NULL
sites	NULL
of	NULL
palmitoylation	NULL
known	NULL
for	NULL
anchoring	NULL
proteins	NULL
to	NULL
lipid	NULL
rafts	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Leck/SHP-1	NULL
chimeric	NULL
molecule	NULL
was	NULL
constructed	NULL
by	NULL
fusion	NULL
of	NULL
the	NULL
14-aa	NULL
N-terminal	NULL
of	NULL
Lek	NULL
to	NULL
a	NULL
full-length	NULL
SHP-1	NULL
phosphatase	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
control	NULL
fusion	NULL
molecule	NULL
was	NULL
made	NULL
with	NULL
a	NULL
catalytically	NULL
inactive	NULL
SHP-1	NULL
(	NULL
AP	NULL
)	NULL
,	NULL
which	NULL
has	NULL
a	NULL
48-aa	NULL
deletion	NULL
in	NULL
the	NULL
PTP	NULL
domain	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
stably	NULL
expressed	NULL
as	NULL
C-terminal	NULL
Myc-tagged	NULL
proteins	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
control	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
Lek/SHP-land	NULL
Leck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
,	NULL
cell	NULL
lines	NULL
were	NULL
selected	NULL
based	NULL
on	NULL
equivalent	NULL
levels	NULL
of	NULL
anti-Myc	NULL
immunoblotting	NULL
.	NULL

Fig	NULL
.	NULL

5B	NULL
shows	NULL
the	NULL
expression	NULL
and	NULL
subcellular	NULL
distribution	NULL
of	NULL
Lek/SHP-1	NULL
and	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
molecules	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
top	NULL
band	NULL
detected	NULL
by	NULL
both	NULL
anti-SHP-1	NULL
and	NULL
anti-Myc	NULL
Ab	NULL
is	NULL
Lek/SHP-1	NULL
,	NULL
which	NULL
is	NULL
24	NULL
aa	NULL
longer	NULL
than	NULL
the	NULL
endogenous	NULL
SHP-1	NULL
(	NULL
middle	NULL
band	NULL
)	NULL
.	NULL

The	NULL
bottom	NULL
band	NULL
is	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
,	NULL
which	NULL
is	NULL
24	NULL
aa	NULL
shorter	NULL
than	NULL
the	NULL
endogenous	NULL
SHP-1	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
endogenous	NULL
SHP-1	NULL
,	NULL
most	NULL
of	NULL
which	NULL
were	NULL
cytosolic	NULL
,	NULL
more	NULL
of	NULL
the	NULL
overexpressed	NULL
Lek/SHP-1	NULL
and	NULL
Leck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
membrane	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
both	NULL
Lek/	NULL
SHP-1and	NULL
Leck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
enriched	NULL
in	NULL
lipid	NULL
rafts	NULL
whereas	NULL
the	NULL
patterns	NULL
of	NULL
membrane	NULL
distribution	NULL
of	NULL
CD3Z	NULL
,	NULL
Lek	NULL
,	NULL
and	NULL
LAT	NULL
were	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3980	NULL
PTPs	NULL
RESTRICT	NULL
CD3-INDUCED	NULL
TYR	NULL
PHOSPHORYLATION	NULL
TO	NULL
LIPID	NULL
RAFTS	NULL
basically	NULL
not	NULL
altered	NULL
and	NULL
resemble	NULL
that	NULL
as	NULL
seen	NULL
in	NULL
wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
5C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
14-aa	NULL
N-terminal	NULL
of	NULL
Lek	NULL
is	NULL
sufficient	NULL
for	NULL
targeting	NULL
SHP-1	NULL
into	NULL
lipid	NULL
microdomains	NULL
.	NULL

Targeting	NULL
of	NULL
Lck/SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
inhibited	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
lipid	NULL
rafts	NULL
,	NULL
IL-2	NULL
generation	NULL
,	NULL
and	NULL
NFAT	NULL
activation	NULL
To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
targeting	NULL
SHP-1	NULL
into	NULL
lipid	NULL
microdomains	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
Lck/SHP-1	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
Ab	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
expressed	NULL
Leck/SHP-1	NULL
chimeric	NULL
molecules	NULL
were	NULL
refractory	NULL
to	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3Z	NULL
and	NULL
CD3e	NULL
in	NULL
the	NULL
lipid	NULL
raft	NULL
fraction	NULL
.	NULL

However	NULL
,	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
the	NULL
mutant	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
construct	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3¢	NULL
and	NULL
CD3¢e	NULL
appeared	NULL
similar	NULL
to	NULL
that	NULL
detected	NULL
in	NULL
wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
CD3-induced	NULL
phosphorylation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
catalytic	NULL
domain	NULL
of	NULL
SHP-1	NULL
phospha-tase	NULL
,	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
inhibition	NULL
is	NULL
not	NULL
attributable	NULL
to	NULL
simple	NULL
displacement	NULL
of	NULL
endogenous	NULL
Lock	NULL
from	NULL
lipid	NULL
rafts	NULL
.	NULL

The	NULL
functional	NULL
consequence	NULL
of	NULL
targeting	NULL
Lek/SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
was	NULL
analyzed	NULL
for	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
NF-AT	NULL
,	NULL
a	NULL
T	NULL
cell-specific	NULL
transcriptional	NULL
factor	NULL
necessary	NULL
for	NULL
IL-2	NULL
gene	NULL
expression	NULL
and	NULL
IL-2	NULL
generation	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
demonstrated	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
A	NULL
ba	NULL
©	NULL
__	NULL
OKT3+PMA	NULL
w	NULL
©	NULL
ta	NULL
a	NULL
NFAT	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
over	NULL
basal	NULL
)	NULL
ta	NULL
Jurkat	NULL
Lck/SHP-1	NULL
(	NULL
aP	NULL
)	NULL
__	NULL
Lek/SHP-1	NULL
12000	NULL
,	NULL
OKT3+PMA	NULL
1000	NULL
{	NULL
8000	NULL
6000	NULL
.	NULL

IL-2	NULL
(	NULL
pgm	NULL
!	NULL
)	NULL

4000	NULL
2000	NULL
J	NULL
WT	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
LcW/SHP-1	NULL
Lck/SHP-1	NULL
in	NULL
lipid	NULL
rafts	NULL
inhibited	NULL
profoundly	NULL
the	NULL
mobilization	NULL
of	NULL
NF-AT	NULL
and	NULL
IL-2	NULL
generation	NULL
after	NULL
stimulation	NULL
with	NULL
OKT3	NULL
plus	NULL
PMA	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
is	NULL
again	NULL
dependent	NULL
on	NULL
an	NULL
intact	NULL
catalytic	NULL
domain	NULL
of	NULL
SHP-1	NULL
,	NULL
as	NULL
cells	NULL
expressing	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
were	NULL
largely	NULL
not	NULL
inhibited	NULL
from	NULL
activating	NULL
NF-AT-mediated	NULL
transcription	NULL
and	NULL
IL-2	NULL
generation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lef	NULL
?	NULL
)	NULL

.	NULL

The	NULL
proximal	NULL
events	NULL
of	NULL
TCR-induced	NULL
activation	NULL
can	NULL
be	NULL
bypassed	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
could	NULL
circumvent	NULL
the	NULL
defect	NULL
seen	NULL
in	NULL
Jurakat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
Lck/	NULL
SHP-1	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
inhibition	NULL
imposed	NULL
by	NULL
Leck/SHP-1	NULL
lies	NULL
upstream	NULL
of	NULL
Ras/mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
by	NULL
allowing	NULL
phosphatases	NULL
to	NULL
enter	NULL
lipid	NULL
rafts	NULL
,	NULL
the	NULL
physiological	NULL
boundary	NULL
imposed	NULL
by	NULL
lipid	NULL
microdomains	NULL
is	NULL
disrupted	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
are	NULL
no	NULL
longer	NULL
capable	NULL
of	NULL
responding	NULL
to	NULL
agonist	NULL
ligands	NULL
.	NULL

Discussion	NULL
To	NULL
study	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
PTPs	NULL
down-regulate	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
subdomain	NULL
distribution	NULL
of	NULL
PTPs	NULL
in	NULL
T	NULL
cell	NULL
membrane	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
PTPs	NULL
are	NULL
not	NULL
distributed	NULL
homogeneously	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

After	NULL
sucrose	NULL
density	NULL
gradient	NULL
segregation	NULL
,	NULL
PTP	NULL
activity	NULL
was	NULL
detected	NULL
preferentially	NULL
in	NULL
Triton	NULL
X-100	NULL
soluble	NULL
membrane	NULL
fractions	NULL
,	NULL
=	NULL
a	NULL
&	NULL
PMA+lonomycin	NULL
bo	NULL
E	NULL
3	NULL
:	NULL
NFAT	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
over	NULL
basal	NULL
)	NULL
&	NULL
©	NULL
Jurkat	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
_	NULL
Lek/SHP-1	NULL
16000	NULL
,	NULL
PMA+lonomycin	NULL
14000	NULL
12000	NULL
10000	NULL
1	NULL
8000	NULL
IL-2	NULL
(	NULL
pg/im	NULL
!	NULL
)	NULL

6000	NULL
4000	NULL
1	NULL
2000	NULL
;	NULL
wT	NULL
LeKW/SHP-1	NULL
(	NULL
aP	NULL
)	NULL
__	NULL
Lek/SHP	NULL
FIGURE	NULL
7	NULL
.	NULL

A	NULL
,	NULL
Inhibition	NULL
of	NULL
CD3-induced	NULL
NF-AT	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
expressing	NULL
Lek/SHP-1	NULL
.	NULL

Wild-type	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
Lck/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
or	NULL
expressing	NULL
Lck/SHP-1	NULL
were	NULL
transfected	NULL
with	NULL
pNF-AT-luc	NULL
reporter	NULL
constructs	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
,	NULL
stimulated	NULL
with	NULL
OKT3	NULL
and	NULL
PMA	NULL
(	NULL
Teff	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
right	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NF-AT	NULL
activity	NULL
was	NULL
shown	NULL
as	NULL
folds	NULL
over	NULL
basal	NULL
luciferase	NULL
activity	NULL
before	NULL
stimulation	NULL
.	NULL

B	NULL
,	NULL
Inhibition	NULL
of	NULL
CD3-induced	NULL
IL-2	NULL
generation	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
in	NULL
triples	NULL
with	NULL
plate-bound	NULL
OKT3	NULL
plus	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
0.5	NULL
wM	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
culture	NULL
medium	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
10	NULL
pl	NULL
of	NULL
culture	NULL
supernantants	NULL
were	NULL
examined	NULL
for	NULL
IL-2	NULL
concentration	NULL
by	NULL
ELISA	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
suggesting	NULL
that	NULL
PTPs	NULL
are	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
CD45	NULL
,	NULL
an	NULL
abundant	NULL
transmembrane	NULL
receptor-like	NULL
PTP	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
showing	NULL
that	NULL
membrane-associated	NULL
population	NULL
of	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
are	NULL
also	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Because	NULL
SHP-1	NULL
and	NULL
SHP-2	NULL
are	NULL
more	NULL
potent	NULL
than	NULL
CD45	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
this	NULL
observation	NULL
suggests	NULL
that	NULL
exclusion	NULL
of	NULL
SHP-1land	NULL
SHP-2	NULL
from	NULL
lipid	NULL
rafts	NULL
may	NULL
be	NULL
important	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
TCR	NULL
activation	NULL
.	NULL

Aggregated	NULL
lipid	NULL
rafts	NULL
may	NULL
provide	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
segregating	NULL
PTPs	NULL
from	NULL
PTKs	NULL
.	NULL

In	NULL
resting	NULL
state	NULL
,	NULL
various	NULL
molecules	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
are	NULL
sequestered	NULL
among	NULL
the	NULL
small	NULL
and	NULL
discrete	NULL
clusters	NULL
of	NULL
lipid	NULL
rafts	NULL
.	NULL

In	NULL
this	NULL
physical	NULL
state	NULL
,	NULL
phosphatases	NULL
like	NULL
SHP-1	NULL
and	NULL
CD45	NULL
can	NULL
readily	NULL
dominate	NULL
and	NULL
interfere	NULL
with	NULL
the	NULL
initiation	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

However	NULL
,	NULL
when	NULL
lipid	NULL
rafts	NULL
are	NULL
aggregated	NULL
by	NULL
receptor	NULL
cross-linking	NULL
or	NULL
when	NULL
concentrated	NULL
in	NULL
a	NULL
specific	NULL
contact	NULL
area	NULL
between	NULL
T	NULL
cells	NULL
and	NULL
APCs	NULL
,	NULL
a	NULL
large	NULL
patch	NULL
of	NULL
the	NULL
membrane	NULL
formed	NULL
by	NULL
the	NULL
coalescence	NULL
of	NULL
smaller	NULL
clusters	NULL
of	NULL
lipid	NULL
rafts	NULL
may	NULL
bring	NULL
together	NULL
molecules	NULL
like	NULL
CD34	NULL
,	NULL
Lck	NULL
,	NULL
and	NULL
LAT	NULL
and	NULL
expel	NULL
PTPs	NULL
from	NULL
the	NULL
contact	NULL
area	NULL
.	NULL

Aggregated	NULL
lipid	NULL
rafts	NULL
may	NULL
impose	NULL
a	NULL
physical	NULL
barrier	NULL
that	NULL
further	NULL
distances	NULL
phosphatases	NULL
from	NULL
their	NULL
potential	NULL
substrates	NULL
,	NULL
thus	NULL
creating	NULL
an	NULL
environment	NULL
within	NULL
lipid	NULL
rafts	NULL
that	NULL
would	NULL
favor	NULL
unrestrained	NULL
kinase	NULL
activity	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
finding	NULL
reinforced	NULL
the	NULL
notion	NULL
that	NULL
exclusion	NULL
of	NULL
PTPs	NULL
from	NULL
T	NULL
cell	NULL
activation	NULL
domain	NULL
or	NULL
segregation	NULL
of	NULL
PTPs	NULL
from	NULL
receptor/PTKs	NULL
complexes	NULL
by	NULL
lipid	NULL
rafts	NULL
may	NULL
potentiate	NULL
the	NULL
initiation	NULL
of	NULL
receptor	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
results	NULL
demonstrating	NULL
that	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD3Z	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
lipid	NULL
rafts	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Our	NULL
observations	NULL
indicate	NULL
that	NULL
a	NULL
fraction	NULL
of	NULL
SHP-1	NULL
was	NULL
constitutively	NULL
associated	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
this	NULL
association	NULL
is	NULL
currently	NULL
unclear	NULL
.	NULL

A	NULL
plausible	NULL
explanation	NULL
would	NULL
be	NULL
the	NULL
association	NULL
between	NULL
Sre	NULL
homology	NULL
2	NULL
domains	NULL
of	NULL
SHP-1	NULL
and	NULL
tyrosine-phosphorylated	NULL
residues	NULL
of	NULL
transmembrane	NULL
receptors	NULL
or	NULL
anchors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
recently	NULL
identified	NULL
leukocyte-associated	NULL
Ig-like	NULL
receptor-1	NULL
and	NULL
SHPS-1	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

This	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
increased	NULL
association	NULL
of	NULL
SHP-1	NULL
with	NULL
plasma	NULL
membrane	NULL
of	NULL
vanadate-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

SHP-1	NULL
in	NULL
untreated	NULL
cells	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
transmembrane	NULL
receptors	NULL
that	NULL
have	NULL
a	NULL
low	NULL
level	NULL
of	NULL
basal	NULL
phosphorylation	NULL
.	NULL

The	NULL
association	NULL
of	NULL
SHP-2	NULL
with	NULL
T	NULL
cell	NULL
membrane	NULL
is	NULL
dependent	NULL
on	NULL
vanadate	NULL
or	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

Several	NULL
transmembrane	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
CTLA-4	NULL
,	NULL
SIRP	NULL
(	NULL
SHPS-1	NULL
)	NULL
,	NULL
and	NULL
PZR	NULL
contain	NULL
the	NULL
immunoreceptor	NULL
tyrosine-based	NULL
inhibitory	NULL
motifs	NULL
that	NULL
are	NULL
potential	NULL
membrane	NULL
anchors	NULL
for	NULL
SHP-2	NULL
(	NULL
31-33	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
,	NULL
though	NULL
,	NULL
that	NULL
a	NULL
small	NULL
but	NULL
significant	NULL
amount	NULL
of	NULL
SHP-2	NULL
was	NULL
detected	NULL
in	NULL
lipid	NULL
rafts	NULL
on	NULL
T	NULL
cell	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
association	NULL
of	NULL
Grb2	NULL
with	NULL
SHP-2	NULL
,	NULL
because	NULL
Grb2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enter	NULL
lipid	NULL
rafts	NULL
upon	NULL
phosphorylation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

SHP-2	NULL
is	NULL
so	NULL
far	NULL
the	NULL
only	NULL
PTPs	NULL
shown	NULL
to	NULL
translocate	NULL
into	NULL
lipid	NULL
rafts	NULL
on	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
and	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
this	NULL
observation	NULL
warrants	NULL
further	NULL
studies	NULL
.	NULL

To	NULL
address	NULL
the	NULL
biological	NULL
significance	NULL
of	NULL
PTP	NULL
exclusion	NULL
from	NULL
lipid	NULL
rafts	NULL
,	NULL
we	NULL
targeted	NULL
SHP-1	NULL
into	NULL
lipid	NULL
rafts	NULL
by	NULL
using	NULL
the	NULL
14-aa	NULL
N-terminal	NULL
of	NULL
Lek	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
lipid	NULL
rafts	NULL
targeting	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
Lek/SHP-1	NULL
in	NULL
lipid	NULL
rafts	NULL
inhibited	NULL
CD3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
CD32	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
generation	NULL
and	NULL
NF-AT-mediated	NULL
transcriptional	NULL
activation	NULL
(	NULL
Figs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
,	NULL
overex-pression	NULL
of	NULL
the	NULL
wild-type	NULL
SHP-1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
affect	NULL
T	NULL
cell	NULL
function	NULL
;	NULL
thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
increased	NULL
phosphatase	NULL
activity	NULL
of	NULL
Lck/SHP-1	NULL
alone	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
inhibition	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
by	NULL
using	NULL
the	NULL
14-aa	NULL
N-terminal	NULL
of	NULL
Lek	NULL
as	NULL
a	NULL
targeting	NULL
strategy	NULL
did	NULL
not	NULL
result	NULL
in	NULL
the	NULL
displacement	NULL
of	NULL
endogenous	NULL
Lock	NULL
from	NULL
lipid	NULL
3981	NULL
rafts	NULL
,	NULL
as	NULL
the	NULL
control	NULL
Lek/SHP-1	NULL
(	NULL
AP	NULL
)	NULL
chimera	NULL
did	NULL
not	NULL
inhibit	NULL
CD3-induced	NULL
signaling	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
surmise	NULL
that	NULL
the	NULL
Leck/SHP-1	NULL
chimeric	NULL
molecule	NULL
was	NULL
able	NULL
to	NULL
breach	NULL
the	NULL
physical	NULL
barrier	NULL
imposed	NULL
by	NULL
lipid	NULL
rafts	NULL
,	NULL
gaining	NULL
access	NULL
to	NULL
the	NULL
potential	NULL
substrates	NULL
that	NULL
otherwise	NULL
would	NULL
not	NULL
be	NULL
available	NULL
.	NULL

Collectively	NULL
,	NULL
our	NULL
results	NULL
strongly	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
phosphatases	NULL
,	NULL
such	NULL
as	NULL
SHP-1	NULL
,	NULL
SHP-2	NULL
,	NULL
and	NULL
CD45	NULL
,	NULL
are	NULL
normally	NULL
excluded	NULL
from	NULL
lipid	NULL
rafts	NULL
,	NULL
and	NULL
their	NULL
restricted	NULL
distribution	NULL
may	NULL
serve	NULL
a	NULL
unique	NULL
function	NULL
in	NULL
regulating	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Ben	NULL
Neel	NULL
(	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
the	NULL
fusion	NULL
plasmids	NULL
of	NULL
GST-SHP-1	NULL
(	NULL
full	NULL
length	NULL
)	NULL
and	NULL
GST-SHP-2	NULL
(	NULL
full	NULL
length	NULL
)	NULL
and	NULL
Dr.	NULL
Haruo	NULL
Saito	NULL
(	NULL
Department	NULL
of	NULL
Cancer	NULL
Immunology	NULL
&	NULL
AIDS	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
the	NULL
fusion	NULL
plasmid	NULL
of	NULL
GST-CD45	NULL
(	NULL
intracellular	NULL
region	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Klausner	NULL
.	NULL

1992	NULL
.	NULL

Tyrosine	NULL
kinases	NULL
and	NULL
tyrosine-based	NULL
activation	NULL
motifs	NULL
:	NULL
current	NULL
research	NULL
on	NULL
activation	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24913	NULL
.	NULL

2	NULL
.	NULL

Wange	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1996	NULL
.	NULL

Complex	NULL
complexes	NULL
:	NULL
signaling	NULL
at	NULL
the	NULL
TCR	NULL
.	NULL

Immunity	NULL
5:197	NULL
.	NULL

3	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
J.	NULL
D.	NULL
Fraser	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
{	NULL
-chain	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
tyrosine	NULL
kinase	NULL
and	NULL
upon	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
associates	NULL
with	NULL
ZAP-70	NULL
,	NULL
a	NULL
70-kDa	NULL
tyrosine	NULL
phosphoprotein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9166	NULL
.	NULL

4	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
M.	NULL
Iwashima	NULL
,	NULL
C.	NULL
W.	NULL
Turck	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

ZAP-70	NULL
:	NULL
a	NULL
70	NULL
kd	NULL
protein-tyrosine	NULL
kinase	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
TCR4	NULL
chain	NULL
.	NULL

Cell	NULL
71:649	NULL
.	NULL

5	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
CD3	NULL
chains	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
associate	NULL
with	NULL
the	NULL
ZAP-70	NULL
tyrosine	NULL
kinase	NULL
and	NULL
are	NULL
tyrosine	NULL
phosphorylated	NULL
after	NULL
receptor	NULL
stimulation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1523	NULL
.	NULL

6	NULL
.	NULL

Clements	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
N.	NULL
J.	NULL
Boerth	NULL
,	NULL
J.	NULL
R.	NULL
Lee	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
.	NULL

1999	NULL
.	NULL

Integration	NULL
of	NULL
T	NULL
cell	NULL
receptor-dependent	NULL
signaling	NULL
pathways	NULL
by	NULL
adapter	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

17:89	NULL
.	NULL

7	NULL
.	NULL

Myung	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
N.	NULL
J.	NULL
Boerthe	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
.	NULL

2000	NULL
.	NULL

Adapter	NULL
proteins	NULL
in	NULL
lymphocyte	NULL
antigen-receptor	NULL
signaling	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

12:256	NULL
.	NULL

8.	NULL
van	NULL
Lecuwen	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1999	NULL
.	NULL

T	NULL
cell	NULL
antigen-receptor	NULL
signal	NULL
transduction	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

11:242	NULL
.	NULL

9	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
1996	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:259	NULL
.	NULL

10	NULL
.	NULL

Xavier	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1999	NULL
.	NULL

Membrane	NULL
compartmentation	NULL
and	NULL
the	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

11:265	NULL
.	NULL

11	NULL
.	NULL

Viola	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Schroeder	NULL
,	NULL
Y.	NULL
Sakakibara	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1999	NULL
.	NULL

T	NULL
lymphocyte	NULL
costimulation	NULL
mediated	NULL
by	NULL
reorganization	NULL
of	NULL
membrane	NULL
microdomains	NULL
.	NULL

Science	NULL
283:680	NULL
.	NULL

12	NULL
.	NULL

Moran	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Miceli	NULL
.	NULL

1998	NULL
.	NULL

Engagement	NULL
of	NULL
GPT-linked	NULL
CD48	NULL
contributes	NULL
to	NULL
TCR	NULL
signals	NULL
and	NULL
cytoskeletal	NULL
reorganization	NULL
:	NULL
a	NULL
role	NULL
for	NULL
lipid	NULL
rafts	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
9:787	NULL
.	NULL

13	NULL
.	NULL

Langlet	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
M.	NULL
Bernard	NULL
,	NULL
P.	NULL
Drevot	NULL
,	NULL
and	NULL
H.	NULL
T.	NULL
He	NULL
.	NULL

2000	NULL
.	NULL

Membrane	NULL
rafts	NULL
and	NULL
signaling	NULL
by	NULL
the	NULL
multichain	NULL
immune	NULL
recognition	NULL
receptors	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

12:250	NULL
.	NULL

14	NULL
.	NULL

Brown	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Rose	NULL
.	NULL

1992	NULL
.	NULL

Sorting	NULL
of	NULL
GPI-anchored	NULL
proteins	NULL
to	NULL
glycolipid-enriched	NULL
membrane	NULL
subdomains	NULL
during	NULL
transport	NULL
to	NULL
the	NULL
apical	NULL
cell	NULL
surface	NULL
.	NULL

Cell	NULL
68:533	NULL
.	NULL

15	NULL
.	NULL

Thomas	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
glycophosphatidylinositol-an-chored	NULL
Thy-1	NULL
molecule	NULL
interacts	NULL
with	NULL
the	NULL
p6Ofyn	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:12317	NULL
.	NULL

16	NULL
.	NULL

Shenoy-Scaria	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
J.	NULL
Kwong	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
M.	NULL
W.	NULL
Olszowy	NULL
,	NULL
A.	NULL
S.	NULL
Shaw	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Lublin	NULL
.	NULL

1992	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
decay-accelerating	NULL
factor	NULL
:	NULL
nter-action	NULL
of	NULL
glycosyl-phosphatidylinositol	NULL
anchor	NULL
and	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
p56	NULL
and	NULL
p594	NULL
``	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3535	NULL
.	NULL

17	NULL
.	NULL

Stefanova	NULL
,	NULL
I.	NULL
,	NULL
V.	NULL
Horejsi	NULL
,	NULL
I.	NULL
J.	NULL
Ansotegui	NULL
,	NULL
W.	NULL
Knapp	NULL
,	NULL
and	NULL
H.	NULL
Stockinger	NULL
.	NULL

1991	NULL
.	NULL

GPI-anchored	NULL
cell-surface	NULL
molecules	NULL
complexed	NULL
to	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Science	NULL
254:1016	NULL
.	NULL

18	NULL
.	NULL

Parolini	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
Sargiacomo	NULL
,	NULL
M.	NULL
P.	NULL
Lisanti	NULL
,	NULL
and	NULL
C.	NULL
Peschle	NULL
.	NULL

1996	NULL
.	NULL

Signal	NULL
transduction	NULL
and	NULL
glycophosphatidylinositol-linked	NULL
proteins	NULL
(	NULL
lyn	NULL
,	NULL
Ick	NULL
,	NULL
CD4	NULL
,	NULL
CD45	NULL
,	NULL
G	NULL
proteins	NULL
,	NULL
and	NULL
CD55	NULL
)	NULL
selectively	NULL
localize	NULL
in	NULL
Triton-insoluble	NULL
plasma	NULL
membrane	NULL
domains	NULL
of	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
and	NULL
normal	NULL
granulocytes	NULL
.	NULL

Blood	NULL
87:3783	NULL
.	NULL

19	NULL
.	NULL

Parolini	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Topa	NULL
,	NULL
M.	NULL
Sorice	NULL
,	NULL
A	NULL
.	NULL

Pace	NULL
,	NULL
P.	NULL
Ceddia	NULL
,	NULL
E.	NULL
Montesoro	NULL
,	NULL
A.	NULL
Pavan	NULL
,	NULL
M.	NULL
P.	NULL
Lisanti	NULL
,	NULL
C.	NULL
Peschle	NULL
,	NULL
and	NULL
M.	NULL
Sargiacomo	NULL
.	NULL

1999	NULL
.	NULL

Phorbol	NULL
ester-induced	NULL
disruption	NULL
of	NULL
the	NULL
CD4-Lck	NULL
complex	NULL
occurs	NULL
within	NULL
a	NULL
detergent-resistant	NULL
microdomain	NULL
of	NULL
the	NULL
plasma	NULL
membrane	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
translocation	NULL
of	NULL
activated	NULL
protein	NULL
kinase	NULL
C	NULL
isoforms	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:14176	NULL
.	NULL

20	NULL
.	NULL

Xavier	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Brennan	NULL
,	NULL
Q.	NULL
Li	NULL
,	NULL
C.	NULL
McCormack	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1998	NULL
.	NULL

Membrane	NULL
compartmentation	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunity	NULL
8:723	NULL
.	NULL

21	NULL
.	NULL

Rodgers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Rose	NULL
.	NULL

1996	NULL
.	NULL

Exclusion	NULL
of	NULL
CD45	NULL
inhibits	NULL
activity	NULL
of	NULL
p56	NULL
``	NULL
associated	NULL
with	NULL
glycolipid-enriched	NULL
membrane	NULL
domains	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

135:1515	NULL
.	NULL

22	NULL
.	NULL

Trowbridge	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

1994	NULL
.	NULL

CD45	NULL
:	NULL
an	NULL
emerging	NULL
role	NULL
as	NULL
a	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
required	NULL
for	NULL
lymphocyte	NULL
activation	NULL
and	NULL
development	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:85	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
3982	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

Scharenberg	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Kinet	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
emerging	NULL
field	NULL
of	NULL
receptor-me-diated	NULL
inhibitory	NULL
signaling	NULL
:	NULL
SHP	NULL
or	NULL
SHIP	NULL
?	NULL

Cell	NULL
87:961	NULL
.	NULL

Neel	NULL
,	NULL
B.	NULL
G.	NULL
1997	NULL
.	NULL

Role	NULL
of	NULL
phosphatases	NULL
in	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:405	NULL
.	NULL

Lorenz	NULL
,	NULL
U.	NULL
,	NULL
K.	NULL
S.	NULL
Ravichandran	NULL
,	NULL
S.	NULL
J.	NULL
Burakoff	NULL
,	NULL
and	NULL
B.	NULL
G.	NULL
Neel	NULL
.	NULL

1996	NULL
.	NULL

Lack	NULL
of	NULL
SHPTP1	NULL
results	NULL
in	NULL
src-family	NULL
kinase	NULL
hyperactivation	NULL
and	NULL
thymocyte	NULL
hyperrespon-siveness	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9624	NULL
.	NULL

Pani	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
D.	NULL
Fischer	NULL
,	NULL
I.	NULL
Mlinaric-Rascan	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Siminovitch	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
capacity	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
PTPIC	NULL
tyrosine	NULL
phosphatase	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:839	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
F.	NULL
G.	NULL
LeRoy	NULL
,	NULL
L.	NULL
K.	NULL
Borysiewicz	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Matthews	NULL
.	NULL

1999	NULL
.	NULL

TCR	NULL
signaling	NULL
thresholds	NULL
regulating	NULL
T	NULL
cell	NULL
development	NULL
and	NULL
activation	NULL
are	NULL
dependent	NULL
upon	NULL
SHP-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3802	NULL
.	NULL

Li	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
Nishimura	NULL
,	NULL
A.	NULL
Kashishian	NULL
,	NULL
A.	NULL
G.	NULL
Batzer	NULL
,	NULL
W.	NULL
J.	NULL
Kim	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Cooper	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
new	NULL
function	NULL
for	NULL
a	NULL
phosphotyrosine	NULL
phosphatase	NULL
:	NULL
linking	NULL
GRB2-Sos	NULL
to	NULL
a	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

14:509	NULL
.	NULL

Tang	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
R.	NULL
M.	NULL
Freeman	NULL
,	NULL
Jr.	NULL
,	NULL
A.	NULL
M.	NULL
O'Reilly	NULL
,	NULL
B.	NULL
G.	NULL
Neel	NULL
,	NULL
and	NULL
S.	NULL
Y.	NULL
Sokol	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
SH2-containing	NULL
protein-tyrosine	NULL
phosphatase	NULL
SH-PTP2	NULL
is	NULL
required	NULL
upstream	NULL
of	NULL
MAP	NULL
kinase	NULL
for	NULL
early	NULL
Xenopus	NULL
development	NULL
.	NULL

Cell	NULL
80:473	NULL
.	NULL

Welham	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
U.	NULL
Dechert	NULL
,	NULL
K.	NULL
B.	NULL
Leslic	NULL
,	NULL
F.	NULL
Jirik	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Schrader	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-3	NULL
and	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
activation	NULL
,	NULL
and	NULL
association	NULL
of	NULL
SHPTP2	NULL
with	NULL
Grb2	NULL
and	NULL
phosphatidylinositol	NULL
3'-kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:23764	NULL
.	NULL

Marengere	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
P.	NULL
Waterhouse	NULL
,	NULL
G.	NULL
S.	NULL
Duncan	NULL
,	NULL
H.	NULL
W.	NULL
Mittrucker	NULL
,	NULL
G.	NULL
S.	NULL
Feng	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
by	NULL
tyrosine	NULL
phosphatase	NULL
SYP	NULL
association	NULL
with	NULL
CTLA-4	NULL
.	NULL

[	NULL
Published	NULL
errata	NULL
appear	NULL
in	NULL
1996	NULL
Science	NULL
274:1597	NULL
and	NULL
1997	NULL
Science	NULL
276:21	NULL
.	NULL
]	NULL

Science	NULL
272:1170	NULL
.	NULL

Lee	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
E.	NULL
Chuang	NULL
,	NULL
M.	NULL
Griffin	NULL
,	NULL
R.	NULL
Khattri	NULL
,	NULL
D.	NULL
K.	NULL
Hong	NULL
,	NULL
W.	NULL
Zhang	NULL
,	NULL
D.	NULL
Straus	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1998	NULL
.	NULL

Molecular	NULL
basis	NULL
of	NULL
T	NULL
cell	NULL
inactivation	NULL
by	NULL
CTLA-4	NULL
.	NULL

Science	NULL
282:2263	NULL
.	NULL

Chuang	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
M.	NULL
Lee	NULL
,	NULL
M.	NULL
D.	NULL
Robbins	NULL
,	NULL
J.	NULL
M.	NULL
Duerr	NULL
,	NULL
M.	NULL
L.	NULL
Alegre	NULL
,	NULL
J.	NULL
E.	NULL
Hambor	NULL
,	NULL
M.	NULL
J.	NULL
Neveu	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1999	NULL
.	NULL

Regulation	NULL
of	NULL
cytotoxic	NULL
T	NULL
lymphocyte-associated	NULL
molecule-4	NULL
by	NULL
Src	NULL
kinases	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:1270	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

PTPs	NULL
RESTRICT	NULL
CD3-INDUCED	NULL
TYR	NULL
PHOSPHORYLATION	NULL
TO	NULL
LIPID	NULL
RAFTS	NULL
Jin	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
J.	NULL
Friedman	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Burakoff	NULL
.	NULL

1998	NULL
.	NULL

Regulation	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
isolated	NULL
T	NULL
cell	NULL
membrane	NULL
by	NULL
inhibition	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1743	NULL
.	NULL

Plas	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
R.	NULL
Johnson	NULL
,	NULL
J.	NULL
T.	NULL
Pingel	NULL
,	NULL
R.	NULL
J.	NULL
Matthews	NULL
,	NULL
M.	NULL
Dalton	NULL
,	NULL
G.	NULL
Roy	NULL
,	NULL
A.	NULL
C.	NULL
Chan	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

1996	NULL
.	NULL

Direct	NULL
regulation	NULL
of	NULL
ZAP-70	NULL
by	NULL
SHP-1	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

Science	NULL
272:1173	NULL
.	NULL

Raab	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
C.	NULL
E.	NULL
Rudd	NULL
.	NULL

1996	NULL
.	NULL

Hematopoietic	NULL
cell	NULL
phosphatase	NULL
(	NULL
HCP	NULL
)	NULL
regulates	NULL
p36	NULL
phosphorylation	NULL
and	NULL
ZAP-70	NULL
binding	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
{	NULL
-chain	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
222:50	NULL
.	NULL

Perez-Villar	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
G.	NULL
S.	NULL
Whitney	NULL
,	NULL
M.	NULL
A.	NULL
Bowen	NULL
,	NULL
D.	NULL
H.	NULL
Hewgill	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Aruffo	NULL
,	NULL
and	NULL
S.	NULL
B.	NULL
Kanner	NULL
.	NULL

1999	NULL
.	NULL

CD5	NULL
negatively	NULL
regulates	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathway	NULL
:	NULL
involvement	NULL
of	NULL
SH2-containing	NULL
phosphotyrosine	NULL
phosphatase	NULL
SHP-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

19:2903	NULL
.	NULL

Xu	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Zhao	NULL
,	NULL
and	NULL
Z.	NULL
J.	NULL
Zhao	NULL
.	NULL

2000	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
leukocyte-associated	NULL
Ig-like	NULL
receptor-1	NULL
as	NULL
a	NULL
major	NULL
anchor	NULL
protein	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
SHP-1	NULL
in	NULL
hematopoictic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275:17440	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Thibaudeau	NULL
,	NULL
and	NULL
S.	NULL
Latour	NULL
.	NULL

1998	NULL
.	NULL

High	NULL
expression	NULL
of	NULL
inhibitory	NULL
receptor	NULL
SHPS-1	NULL
and	NULL
its	NULL
association	NULL
with	NULL
protein-tyrosine	NULL
phosphatase	NULL
SHP-1	NULL
in	NULL
macrophages	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:22719	NULL
.	NULL

Kharitonenkov	NULL
,	NULL
A.	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
I.	NULL
Sures	NULL
,	NULL
H.	NULL
Wang	NULL
,	NULL
J.	NULL
Schilling	NULL
,	NULL
and	NULL
A.	NULL
Ullrich	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
inhibit	NULL
signalling	NULL
through	NULL
tyrosine	NULL
kinase	NULL
receptors	NULL
.	NULL

Nature	NULL
386:181	NULL
.	NULL

Zhao	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Zhao	NULL
.	NULL

1998	NULL
.	NULL

Purification	NULL
and	NULL
cloning	NULL
of	NULL
PZR	NULL
,	NULL
a	NULL
binding	NULL
protein	NULL
and	NULL
putative	NULL
physiological	NULL
substrate	NULL
of	NULL
tyrosine	NULL
phosphatase	NULL
SHP-2	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:29367	NULL
.	NULL

Resh	NULL
,	NULL
M.	NULL
D.	NULL
1996	NULL
.	NULL

Regulation	NULL
of	NULL
cellular	NULL
signalling	NULL
by	NULL
fatty	NULL
acid	NULL
acylation	NULL
and	NULL
prenylation	NULL
of	NULL
signal	NULL
transduction	NULL
proteins	NULL
.	NULL

Cell	NULL
Signal	NULL
8:403	NULL
.	NULL

Tumer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
M.	NULL
H.	NULL
Brodsky	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
S.	NULL
D.	NULL
Levin	NULL
,	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1990	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
unique	NULL
N-terminal	NULL
region	NULL
of	NULL
tyrosine	NULL
kinase	NULL
p56lck	NULL
with	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
is	NULL
mediated	NULL
by	NULL
cys-teine	NULL
motifs	NULL
.	NULL

Cell	NULL
60:755	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

